Recombinant Poliovirus-Like Particle Mutations for Thermal Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current poliovirus-like particles (PVLPs) face challenges in maintaining thermal stability and immunogenicity due to conformational instability, with previous studies focusing primarily on thermal stability without adequate evaluation of immunogenicity.
Innovation Solution
Optimized mutation sites on structural proteins VP1, VP2, and VP3 of poliovirus types I, II, and III, addressing both thermal stability and immunogenicity by introducing specific mutations at protomer, VP2/VP3, pentamer, binding pocket, and internal network interfaces.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If heat passaging and screening of viral variants with thermal stabilizing mutations are performed, then thermal stability of PVLPs is improved, but immunogenicity evaluation is insufficient
Solution Approach 1:
The patent applies parameter changes by systematically varying mutation combinations at identified thermal stability sites (Tm values) and evaluating the resulting PVLPs for both thermal stability and immunogenicity parameters. This allows optimization of multiple parameters simultaneously to resolve the contradiction between thermal stability improvement and immunogenicity evaluation sufficiency.
Solution Approach 2:
The patent implements feedback by using deep sequencing to identify mutation sites, then screening variants based on both thermal stability measurements and immunogenicity assessment. This closed-loop feedback process enables identification of mutation combinations that satisfy both thermal stability requirements and maintain adequate immunogenicity.
2Stability of the object's composition
If multiple mutation sites are optimized on structural proteins, then both thermal stability and immunogenicity are improved, but the complexity of identifying optimal mutation combinations increases
Solution Approach 1:
The patent segments the complex mutation optimization problem by first identifying specific thermal stability sites through deep sequencing, then focusing screening efforts on variants with mutations at these predetermined sites. This segmentation reduces the search space from all possible mutations to a manageable subset at key locations.
Solution Approach 2:
The patent applies partial action by screening a focused set of variants with mutations at identified thermal stability sites rather than exhaustively testing all possible mutations. This partial screening approach efficiently identifies optimal mutation combinations without requiring complete enumeration of all possibilities.
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Provided are a recombinant poliovirus-like particle (PVLP), a preparation method therefor, and a use. The mutation design of the recombinant poliovirus-like particle is based on a structural protein mutation combination, which not only enhances the thermal stability of the PVLP, but also improves the immunogenicity of the PVLP.